BPC-157 promotes angiogenesis (new blood vessel formation) and granulation tissue formation, both critical for repairing inflamed tissues
Unlike traditional treatments, BPC-157 promotes tissue repair, enhances tendon and ligament healing, and may reduce the need for invasive procedures or long-term medication use
Treatment is typically conducted for 812 weeks , after which a break or reassessment period is recommended to evaluate response and progress
The math remains the same 1,000mcg is still 0.1mL at a 10,000mcg/mL concentration but researchers can use the calculator to set consistent baselines when exploring gender-specific responses in studies
Not sure where to start or have questions
That absence is exactly why it remains a research compound